Engineered coiled-coil HIF1α protein domain mimic

The development of targeted anti-cancer therapeutics offers the potential for increased efficacy of drugs and diagnostics. Utilizing modalities agnostic to tumor type, such as the hypoxic tumor microenvironment (TME), may assist in the development of universal tumor targeting agents. The hypoxia-ind...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials science 2024-05, Vol.12 (11), p.2951-2959
Hauptverfasser: Britton, Dustin, Katsara, Olga, Mishkit, Orin, Wang, Andrew, Pandya, Neelam, Liu, Chengliang, Mao, Heather, Legocki, Jakub, Jia, Sihan, Xiao, Yingxin, Aristizabal, Orlando, Paul, Deven, Deng, Yan, Schneider, Robert, Wadghiri, Youssef Z, Montclare, Jin Kim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2959
container_issue 11
container_start_page 2951
container_title Biomaterials science
container_volume 12
creator Britton, Dustin
Katsara, Olga
Mishkit, Orin
Wang, Andrew
Pandya, Neelam
Liu, Chengliang
Mao, Heather
Legocki, Jakub
Jia, Sihan
Xiao, Yingxin
Aristizabal, Orlando
Paul, Deven
Deng, Yan
Schneider, Robert
Wadghiri, Youssef Z
Montclare, Jin Kim
description The development of targeted anti-cancer therapeutics offers the potential for increased efficacy of drugs and diagnostics. Utilizing modalities agnostic to tumor type, such as the hypoxic tumor microenvironment (TME), may assist in the development of universal tumor targeting agents. The hypoxia-inducible factor (HIF), in particular HIF1, plays a key role in tumor adaptation to hypoxia, and inhibiting its interaction with p300 has been shown to provide therapeutic potential. Using a multivalent assembled protein (MAP) approach based on the self-assembly of the cartilage oligomeric matrix protein coiled-coil (COMPcc) domain fused to the critical residues of the C-terminal transactivation domain (C-TAD) of the α subunit of HIF1 (HIF1α), we generate HIF1α-MAP (H-MAP). The resulting H-MAP demonstrates picomolar binding affinity to p300, the ability to downregulate hypoxia-inducible genes, and in vivo tumor targeting capability. Multivalent assembled proteins (MAPs) as protein domain mimics (PDMs) of HIF1α allows for improved tumor targeting.
doi_str_mv 10.1039/d4bm00354c
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_38656316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3060765365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c296t-c7eb1806cbb793e03bbfe9ed8e57b0eb6f3c74953117ff80c308f5e6c4258c3c3</originalsourceid><addsrcrecordid>eNpdkU1Lw0AQhhdRbKm9eFcCXkSIzmY_c9TaaqHiRc8hu5lISj7qbnPwZ_lH_E1uba3gMPAOzMPw8g4hpxSuKbD0puCmAWCC2wMyTICrmGueHu5nBgMy9n4JoZRKQdJjMmBaCsmoHJJk2r5VLaLDIrJdVWMRbyR6nM_o12e0ct0aqzYquiYP0lRNZU_IUZnXHsc7HZHX2fRl8hgvnh_mk9tFbJNUrmOr0FAN0hqjUobAjCkxxUKjUAbQyJJZxVPBKFVlqcEy0KVAaXkitGWWjcjl9m4w8d6jX2dN5S3Wdd5i1_uMAZeCUq15QC_-ocuud21wFygJSgoWekSutpR1nfcOy2zlqiZ3HxmFbBNmds_vnn7CnAT4fHeyNw0We_Q3ugCcbQHn7X779w32DczMdwU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3060765365</pqid></control><display><type>article</type><title>Engineered coiled-coil HIF1α protein domain mimic</title><source>MEDLINE</source><source>Royal Society Of Chemistry Journals 2008-</source><creator>Britton, Dustin ; Katsara, Olga ; Mishkit, Orin ; Wang, Andrew ; Pandya, Neelam ; Liu, Chengliang ; Mao, Heather ; Legocki, Jakub ; Jia, Sihan ; Xiao, Yingxin ; Aristizabal, Orlando ; Paul, Deven ; Deng, Yan ; Schneider, Robert ; Wadghiri, Youssef Z ; Montclare, Jin Kim</creator><creatorcontrib>Britton, Dustin ; Katsara, Olga ; Mishkit, Orin ; Wang, Andrew ; Pandya, Neelam ; Liu, Chengliang ; Mao, Heather ; Legocki, Jakub ; Jia, Sihan ; Xiao, Yingxin ; Aristizabal, Orlando ; Paul, Deven ; Deng, Yan ; Schneider, Robert ; Wadghiri, Youssef Z ; Montclare, Jin Kim</creatorcontrib><description>The development of targeted anti-cancer therapeutics offers the potential for increased efficacy of drugs and diagnostics. Utilizing modalities agnostic to tumor type, such as the hypoxic tumor microenvironment (TME), may assist in the development of universal tumor targeting agents. The hypoxia-inducible factor (HIF), in particular HIF1, plays a key role in tumor adaptation to hypoxia, and inhibiting its interaction with p300 has been shown to provide therapeutic potential. Using a multivalent assembled protein (MAP) approach based on the self-assembly of the cartilage oligomeric matrix protein coiled-coil (COMPcc) domain fused to the critical residues of the C-terminal transactivation domain (C-TAD) of the α subunit of HIF1 (HIF1α), we generate HIF1α-MAP (H-MAP). The resulting H-MAP demonstrates picomolar binding affinity to p300, the ability to downregulate hypoxia-inducible genes, and in vivo tumor targeting capability. Multivalent assembled proteins (MAPs) as protein domain mimics (PDMs) of HIF1α allows for improved tumor targeting.</description><identifier>ISSN: 2047-4830</identifier><identifier>ISSN: 2047-4849</identifier><identifier>EISSN: 2047-4849</identifier><identifier>DOI: 10.1039/d4bm00354c</identifier><identifier>PMID: 38656316</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Animals ; Cartilage Oligomeric Matrix Protein - chemistry ; Cartilage Oligomeric Matrix Protein - metabolism ; Cell Line, Tumor ; Coils ; E1A-Associated p300 Protein - chemistry ; E1A-Associated p300 Protein - metabolism ; Humans ; Hypoxia ; Hypoxia-Inducible Factor 1, alpha Subunit - chemistry ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; Mice ; Protein Domains ; Protein Engineering ; Proteins ; Self-assembly ; Tumor Microenvironment ; Tumors</subject><ispartof>Biomaterials science, 2024-05, Vol.12 (11), p.2951-2959</ispartof><rights>Copyright Royal Society of Chemistry 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c296t-c7eb1806cbb793e03bbfe9ed8e57b0eb6f3c74953117ff80c308f5e6c4258c3c3</cites><orcidid>0000-0001-6857-3591</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38656316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Britton, Dustin</creatorcontrib><creatorcontrib>Katsara, Olga</creatorcontrib><creatorcontrib>Mishkit, Orin</creatorcontrib><creatorcontrib>Wang, Andrew</creatorcontrib><creatorcontrib>Pandya, Neelam</creatorcontrib><creatorcontrib>Liu, Chengliang</creatorcontrib><creatorcontrib>Mao, Heather</creatorcontrib><creatorcontrib>Legocki, Jakub</creatorcontrib><creatorcontrib>Jia, Sihan</creatorcontrib><creatorcontrib>Xiao, Yingxin</creatorcontrib><creatorcontrib>Aristizabal, Orlando</creatorcontrib><creatorcontrib>Paul, Deven</creatorcontrib><creatorcontrib>Deng, Yan</creatorcontrib><creatorcontrib>Schneider, Robert</creatorcontrib><creatorcontrib>Wadghiri, Youssef Z</creatorcontrib><creatorcontrib>Montclare, Jin Kim</creatorcontrib><title>Engineered coiled-coil HIF1α protein domain mimic</title><title>Biomaterials science</title><addtitle>Biomater Sci</addtitle><description>The development of targeted anti-cancer therapeutics offers the potential for increased efficacy of drugs and diagnostics. Utilizing modalities agnostic to tumor type, such as the hypoxic tumor microenvironment (TME), may assist in the development of universal tumor targeting agents. The hypoxia-inducible factor (HIF), in particular HIF1, plays a key role in tumor adaptation to hypoxia, and inhibiting its interaction with p300 has been shown to provide therapeutic potential. Using a multivalent assembled protein (MAP) approach based on the self-assembly of the cartilage oligomeric matrix protein coiled-coil (COMPcc) domain fused to the critical residues of the C-terminal transactivation domain (C-TAD) of the α subunit of HIF1 (HIF1α), we generate HIF1α-MAP (H-MAP). The resulting H-MAP demonstrates picomolar binding affinity to p300, the ability to downregulate hypoxia-inducible genes, and in vivo tumor targeting capability. Multivalent assembled proteins (MAPs) as protein domain mimics (PDMs) of HIF1α allows for improved tumor targeting.</description><subject>Animals</subject><subject>Cartilage Oligomeric Matrix Protein - chemistry</subject><subject>Cartilage Oligomeric Matrix Protein - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Coils</subject><subject>E1A-Associated p300 Protein - chemistry</subject><subject>E1A-Associated p300 Protein - metabolism</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - chemistry</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>Mice</subject><subject>Protein Domains</subject><subject>Protein Engineering</subject><subject>Proteins</subject><subject>Self-assembly</subject><subject>Tumor Microenvironment</subject><subject>Tumors</subject><issn>2047-4830</issn><issn>2047-4849</issn><issn>2047-4849</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1Lw0AQhhdRbKm9eFcCXkSIzmY_c9TaaqHiRc8hu5lISj7qbnPwZ_lH_E1uba3gMPAOzMPw8g4hpxSuKbD0puCmAWCC2wMyTICrmGueHu5nBgMy9n4JoZRKQdJjMmBaCsmoHJJk2r5VLaLDIrJdVWMRbyR6nM_o12e0ct0aqzYquiYP0lRNZU_IUZnXHsc7HZHX2fRl8hgvnh_mk9tFbJNUrmOr0FAN0hqjUobAjCkxxUKjUAbQyJJZxVPBKFVlqcEy0KVAaXkitGWWjcjl9m4w8d6jX2dN5S3Wdd5i1_uMAZeCUq15QC_-ocuud21wFygJSgoWekSutpR1nfcOy2zlqiZ3HxmFbBNmds_vnn7CnAT4fHeyNw0We_Q3ugCcbQHn7X779w32DczMdwU</recordid><startdate>20240528</startdate><enddate>20240528</enddate><creator>Britton, Dustin</creator><creator>Katsara, Olga</creator><creator>Mishkit, Orin</creator><creator>Wang, Andrew</creator><creator>Pandya, Neelam</creator><creator>Liu, Chengliang</creator><creator>Mao, Heather</creator><creator>Legocki, Jakub</creator><creator>Jia, Sihan</creator><creator>Xiao, Yingxin</creator><creator>Aristizabal, Orlando</creator><creator>Paul, Deven</creator><creator>Deng, Yan</creator><creator>Schneider, Robert</creator><creator>Wadghiri, Youssef Z</creator><creator>Montclare, Jin Kim</creator><general>Royal Society of Chemistry</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6857-3591</orcidid></search><sort><creationdate>20240528</creationdate><title>Engineered coiled-coil HIF1α protein domain mimic</title><author>Britton, Dustin ; Katsara, Olga ; Mishkit, Orin ; Wang, Andrew ; Pandya, Neelam ; Liu, Chengliang ; Mao, Heather ; Legocki, Jakub ; Jia, Sihan ; Xiao, Yingxin ; Aristizabal, Orlando ; Paul, Deven ; Deng, Yan ; Schneider, Robert ; Wadghiri, Youssef Z ; Montclare, Jin Kim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c296t-c7eb1806cbb793e03bbfe9ed8e57b0eb6f3c74953117ff80c308f5e6c4258c3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Cartilage Oligomeric Matrix Protein - chemistry</topic><topic>Cartilage Oligomeric Matrix Protein - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Coils</topic><topic>E1A-Associated p300 Protein - chemistry</topic><topic>E1A-Associated p300 Protein - metabolism</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - chemistry</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>Mice</topic><topic>Protein Domains</topic><topic>Protein Engineering</topic><topic>Proteins</topic><topic>Self-assembly</topic><topic>Tumor Microenvironment</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Britton, Dustin</creatorcontrib><creatorcontrib>Katsara, Olga</creatorcontrib><creatorcontrib>Mishkit, Orin</creatorcontrib><creatorcontrib>Wang, Andrew</creatorcontrib><creatorcontrib>Pandya, Neelam</creatorcontrib><creatorcontrib>Liu, Chengliang</creatorcontrib><creatorcontrib>Mao, Heather</creatorcontrib><creatorcontrib>Legocki, Jakub</creatorcontrib><creatorcontrib>Jia, Sihan</creatorcontrib><creatorcontrib>Xiao, Yingxin</creatorcontrib><creatorcontrib>Aristizabal, Orlando</creatorcontrib><creatorcontrib>Paul, Deven</creatorcontrib><creatorcontrib>Deng, Yan</creatorcontrib><creatorcontrib>Schneider, Robert</creatorcontrib><creatorcontrib>Wadghiri, Youssef Z</creatorcontrib><creatorcontrib>Montclare, Jin Kim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>MEDLINE - Academic</collection><jtitle>Biomaterials science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Britton, Dustin</au><au>Katsara, Olga</au><au>Mishkit, Orin</au><au>Wang, Andrew</au><au>Pandya, Neelam</au><au>Liu, Chengliang</au><au>Mao, Heather</au><au>Legocki, Jakub</au><au>Jia, Sihan</au><au>Xiao, Yingxin</au><au>Aristizabal, Orlando</au><au>Paul, Deven</au><au>Deng, Yan</au><au>Schneider, Robert</au><au>Wadghiri, Youssef Z</au><au>Montclare, Jin Kim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineered coiled-coil HIF1α protein domain mimic</atitle><jtitle>Biomaterials science</jtitle><addtitle>Biomater Sci</addtitle><date>2024-05-28</date><risdate>2024</risdate><volume>12</volume><issue>11</issue><spage>2951</spage><epage>2959</epage><pages>2951-2959</pages><issn>2047-4830</issn><issn>2047-4849</issn><eissn>2047-4849</eissn><abstract>The development of targeted anti-cancer therapeutics offers the potential for increased efficacy of drugs and diagnostics. Utilizing modalities agnostic to tumor type, such as the hypoxic tumor microenvironment (TME), may assist in the development of universal tumor targeting agents. The hypoxia-inducible factor (HIF), in particular HIF1, plays a key role in tumor adaptation to hypoxia, and inhibiting its interaction with p300 has been shown to provide therapeutic potential. Using a multivalent assembled protein (MAP) approach based on the self-assembly of the cartilage oligomeric matrix protein coiled-coil (COMPcc) domain fused to the critical residues of the C-terminal transactivation domain (C-TAD) of the α subunit of HIF1 (HIF1α), we generate HIF1α-MAP (H-MAP). The resulting H-MAP demonstrates picomolar binding affinity to p300, the ability to downregulate hypoxia-inducible genes, and in vivo tumor targeting capability. Multivalent assembled proteins (MAPs) as protein domain mimics (PDMs) of HIF1α allows for improved tumor targeting.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>38656316</pmid><doi>10.1039/d4bm00354c</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6857-3591</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2047-4830
ispartof Biomaterials science, 2024-05, Vol.12 (11), p.2951-2959
issn 2047-4830
2047-4849
2047-4849
language eng
recordid cdi_pubmed_primary_38656316
source MEDLINE; Royal Society Of Chemistry Journals 2008-
subjects Animals
Cartilage Oligomeric Matrix Protein - chemistry
Cartilage Oligomeric Matrix Protein - metabolism
Cell Line, Tumor
Coils
E1A-Associated p300 Protein - chemistry
E1A-Associated p300 Protein - metabolism
Humans
Hypoxia
Hypoxia-Inducible Factor 1, alpha Subunit - chemistry
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Mice
Protein Domains
Protein Engineering
Proteins
Self-assembly
Tumor Microenvironment
Tumors
title Engineered coiled-coil HIF1α protein domain mimic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A26%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineered%20coiled-coil%20HIF1%CE%B1%20protein%20domain%20mimic&rft.jtitle=Biomaterials%20science&rft.au=Britton,%20Dustin&rft.date=2024-05-28&rft.volume=12&rft.issue=11&rft.spage=2951&rft.epage=2959&rft.pages=2951-2959&rft.issn=2047-4830&rft.eissn=2047-4849&rft_id=info:doi/10.1039/d4bm00354c&rft_dat=%3Cproquest_pubme%3E3060765365%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3060765365&rft_id=info:pmid/38656316&rfr_iscdi=true